Back to Search
JEFFREY RAIZER, MD
MD
Neurology Physician
NPI: 1609807635IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
036109550(IL)
Education
NEW YORK MEDICAL COLLEGE
Class of 1991
Research & Publications (20)
Response of an adult patient with pineoblastoma to vorinostat and retinoic acid.
PMID 19506816·J Neurooncol·2009
5-case
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
PMID 18287337·Neuro Oncol·2008
8-other
The evolving role of radiosurgery for metastatic spine tumors.
PMID 17646859·Nat Clin Pract Neurol·2007
8-other
HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
PMID 16078112·J Neurooncol·2005
6-review
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
PMID 15690135·J Neurooncol·2005
8-other
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
PMID 15279717·Neuro Oncol·2004
3-trial
Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literature.
PMID 19618118·J Neurooncol·2010
5-case
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia.
PMID 19099199·J Neurooncol·2009
8-other
Antiangiogenic therapy for high-grade gliomas.
PMID 19601816·CNS Neurol Disord Drug Targets·2009
6-review
Quantification of cerebral perfusion using the "bookend technique": an evaluation in CNS tumors.
PMID 18538523·Magn Reson Imaging·2008
8-other
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
PMID 18936428·Neurology·2008
4-observational
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
PMID 17987262·J Neurooncol·2008
3-trial
Immunotherapeutic treatment strategies for primary brain tumors.
PMID 18363109·Curr Treat Options Oncol·2008
6-review
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
PMID 18458821·J Neurooncol·2008
3-trial
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
PMID 18981465·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 680 N LAKE SHORE DR, SUITE 1000
CHICAGO, IL 60611 - Phone
- (312) 695-9797
Quick Facts
- NPI
- 1609807635
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile